冠状动脉支架:所有这些试验
Margaret Mary Glazier1, James J Glazier2,3
1Department of Medicine, Tufts Medical Center, Boston, Massachusetts.
概括
冠状动脉支架已经发生了显著的进化,通过减少复缩和突然关闭来改善血管造形术的结果. 较新的药物释放支架提供较低的血栓形成率,但手术可能更适合复杂的冠状动脉疾病.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 生物材料工程 生物材料工程
背景情况:
- 冠状动脉支架是为了解决气球血管造形术的局限性而开发的,特别是高复原率和血管突然关闭.
- 早期的试验证实了支架在动脉支架和减少静脉缩方面的效果,与单独使用气球血管造形术相比.
研究的目的:
- 审查冠状动脉支架技术的发展及其对患者治疗结果的影响.
- 评估各种支架类型的有效性和安全性,包括裸金属,药物排泄和生物可吸收支架.
- 为了比较穿皮冠状动脉干预 (PCI) 与药物释放支架与冠状动脉旁路手术 (CABS) 复杂冠状动脉疾病.
主要方法:
- 对关键临床试验的审查,包括BENESTENT-I,STRESS,Sirius,ABSORB II和SYNTAX. 这三种药物.
- 在不同的支架世代中分析复缩率,支架血栓形成和再血管化需求.
- 在复杂的多血管和左主冠状动脉疾病中,PCI结果与手术重血管化的比较.
主要成果:
- 与气球血管整形相比,支架显著降低了复缩率.
- 第一代药物排泄支架 (DES) 降低了瘤重血管化,但引起了对支架血栓形成的担忧.
- 第二代DES表现出非常低的支架血栓形成率 (<1%). 可生物吸收的支架显示承诺减少.
- 在SYNTAX试验中,CABS可能在左主血管和多血管疾病中优于PCI与DES.
结论:
- 冠状动脉支架技术已经进步,为冠状动脉疾病患者提供了更好的治疗结果.
- 虽然DES已经成为标准,但谨慎的患者选择至关重要,CABS仍然是复杂疾病的首选选择.
- 目前正在进行的研究继续改进支架设计并优化冠状动脉疾病的治疗策略.
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
200
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200
01:27Coronary Artery Disease V: Interprofessional Care
207
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
207
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:30Coronary Artery Disease III: Clinical Manifestations
313
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
313
01:26Coronary Artery Disease IV: Preventive Measures
578
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
578